The story of Viagra, and its parent company copyright, presents a intriguing case study for investors. At first a blockbuster drug, producing billions in revenue , its exclusivity period created a deluge of https://bookmarkmoz.com/story21433541/copyright-s-pill-and-the-pharmaceutical-sector-a-risky-opportunity